JP2016508026A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016508026A5 JP2016508026A5 JP2015542310A JP2015542310A JP2016508026A5 JP 2016508026 A5 JP2016508026 A5 JP 2016508026A5 JP 2015542310 A JP2015542310 A JP 2015542310A JP 2015542310 A JP2015542310 A JP 2015542310A JP 2016508026 A5 JP2016508026 A5 JP 2016508026A5
- Authority
- JP
- Japan
- Prior art keywords
- pca
- category
- composite value
- biomarker
- snppc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1251310-7 | 2012-11-20 | ||
| SE1251310 | 2012-11-20 | ||
| SE1350602 | 2013-05-16 | ||
| SE1350602-7 | 2013-05-16 | ||
| PCT/EP2013/074270 WO2014079874A1 (en) | 2012-11-20 | 2013-11-20 | Prognostic method for individuals with prostate cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016508026A JP2016508026A (ja) | 2016-03-17 |
| JP2016508026A5 true JP2016508026A5 (https=) | 2017-01-05 |
Family
ID=49713059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015542310A Pending JP2016508026A (ja) | 2012-11-20 | 2013-11-20 | 前立腺癌を有する個体の予後診断方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10428385B2 (https=) |
| EP (1) | EP2922970B1 (https=) |
| JP (1) | JP2016508026A (https=) |
| AU (1) | AU2013349721B2 (https=) |
| CA (1) | CA2891394C (https=) |
| ES (1) | ES2694409T3 (https=) |
| RU (1) | RU2669809C2 (https=) |
| WO (1) | WO2014079874A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI596494B (zh) | 2012-03-05 | 2017-08-21 | Ｏｐｋｏ診斷法有限責任公司 | 預測前列腺癌風險及前列腺腺體體積之方法及裝置 |
| US10431326B2 (en) | 2012-11-20 | 2019-10-01 | Phadia Ab | Method for indicating a presence or non-presence of aggressive prostate cancer |
| FI3117216T3 (fi) * | 2014-03-11 | 2023-04-27 | Phadia Ab | Menetelmä kiinteäkasvaimisen syövän tunnistamiseksi |
| US12326453B2 (en) | 2014-03-28 | 2025-06-10 | Opko Diagnostics, Llc | Compositions and methods for active surveillance of prostate cancer |
| KR102505543B1 (ko) | 2014-03-28 | 2023-03-02 | 옵코 다이어그노스틱스, 엘엘씨 | 전립선암 진단에 관한 조성물 및 방법 |
| PT3253800T (pt) | 2015-03-27 | 2021-04-28 | Opko Diagnostics Llc | Padrões de antigénio da próstata e suas utilizações |
| KR102527446B1 (ko) * | 2015-04-29 | 2023-05-02 | 옵코 다이어그노스틱스, 엘엘씨 | 전립선암의 적극적 감시를 위한 조성물 및 방법 |
| JP6570929B2 (ja) * | 2015-09-08 | 2019-09-04 | 国立研究開発法人農業・食品産業技術総合研究機構 | 特性推定モデル生成装置および方法、解析対象の特性推定装置および方法 |
| WO2018141828A1 (en) * | 2017-02-01 | 2018-08-09 | Phadia Ab | Method for indicating a presence or non-presence of prostate cancer in individuals with particular characteristics |
| KR20200112922A (ko) * | 2018-01-22 | 2020-10-05 | 파디아 에이비 | 분석 결과를 조화시키는 방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582908B2 (en) * | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
| IN2009DN05722A (https=) | 2007-02-07 | 2015-07-24 | Decode Genetics Ehf | |
| WO2012031207A2 (en) * | 2010-09-03 | 2012-03-08 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with prostate cancer risk |
| US20120202888A1 (en) | 2010-10-08 | 2012-08-09 | The Brigham And Women's Hospital, Inc. | Biomarkers of prostate cancer and predicting mortality |
| US20120150032A1 (en) * | 2010-12-13 | 2012-06-14 | Julius Gudmundsson | Sequence Variants Associated with Prostate Specific Antigen Levels |
| EP2850432A2 (en) | 2012-05-16 | 2015-03-25 | Phadia AB | Method for indicating the presence or non-presence of prostate cancer |
| US10431326B2 (en) | 2012-11-20 | 2019-10-01 | Phadia Ab | Method for indicating a presence or non-presence of aggressive prostate cancer |
-
2013
- 2013-11-20 EP EP13799501.5A patent/EP2922970B1/en active Active
- 2013-11-20 JP JP2015542310A patent/JP2016508026A/ja active Pending
- 2013-11-20 WO PCT/EP2013/074270 patent/WO2014079874A1/en not_active Ceased
- 2013-11-20 CA CA2891394A patent/CA2891394C/en active Active
- 2013-11-20 AU AU2013349721A patent/AU2013349721B2/en active Active
- 2013-11-20 US US14/443,974 patent/US10428385B2/en active Active
- 2013-11-20 ES ES13799501.5T patent/ES2694409T3/es active Active
- 2013-11-20 RU RU2015124008A patent/RU2669809C2/ru active
-
2019
- 2019-09-19 US US16/575,940 patent/US20200010912A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016503301A5 (https=) | ||
| JP2016508026A5 (https=) | ||
| AU2021232712B2 (en) | Method for detecting a solid tumor cancer | |
| Takeuchi et al. | The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer | |
| Okamura et al. | Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepatocellular carcinoma | |
| Prensner et al. | RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1 | |
| Bonne et al. | Salivary biomarker development using genomic, proteomic and metabolomic approaches | |
| JP2019049559A (ja) | 侵攻性前立腺癌の存在または不存在を判定する方法 | |
| Martuszewski et al. | Donor-derived cell-free DNA in kidney transplantation as a potential rejection biomarker: a systematic literature review | |
| Zhao et al. | Levels of plasma Epstein-Barr virus DNA prior and subsequent to treatment predicts the prognosis of nasopharyngeal carcinoma | |
| Wang et al. | Identification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma | |
| JP2017508970A5 (https=) | ||
| JP2015524052A (ja) | 前立腺癌の存在または不存在の提示方法 | |
| ES2694409T3 (es) | Método de pronóstico para individuos con cáncer de próstata | |
| Irvine et al. | Multiplex serum protein analysis identifies novel biomarkers of advanced fibrosis in patients with chronic liver disease with the potential to improve diagnostic accuracy of established biomarkers | |
| CN107657149B (zh) | 用于预测肝癌患者预后的系统 | |
| Léon et al. | Comparison of cell cycle progression score with two immunohistochemical markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomy | |
| Fu et al. | A novel and validated inflammation-based score (IBS) predicts survival in patients with hepatocellular carcinoma following curative surgical resection: a STROBE-compliant article | |
| Wu et al. | The prediction of epidermal growth factor receptor mutation and prognosis of EGFR tyrosine kinase inhibitor by serum ferritin in advanced NSCLC | |
| Yang et al. | Diagnostic value of circulating microRNAs for hepatocellular carcinoma | |
| JP2020505928A (ja) | 特定の特徴を有する個体において前立腺癌の存在または不存在を示すための方法 | |
| Do et al. | Detection of sFas, sCD137, and IL-27 cytokines as potential biomarkers for hepatocellular carcinoma diagnosis | |
| Yang et al. | Gustative Roussy Immune Score is a Predictor for Major Pathological Response in Rectal Cancer: A Result from the Preoperative Intraarterial Chemoembolization Combined with Radiotherapy (PCAR) Study | |
| Zou et al. | Identification and validation of a ten-gene set variation score as a diagnostic and prognostic stratification tool in hepatocellular carcinoma | |
| US20250210192A1 (en) | Methods for disease detection |